In today’s episode, we’ll be looking at considerations for Medical Affairs in Rare Disease and Gene Therapy
The transformation is happening now. Discover how Medical Affairs teams are evolving from an executional hub to a strategic pillar, resonating and reconciling the voice of the patient and clinicians, and driving insights to their organization. Using the MAPS Medical Affairs Vision 2030 as our roadmap, experts will discuss the criticality of:
This White Paper provides a foundational understanding of insights management, including the definition and value of insights, processes and technologies for insights management, and key challenges in implementation.
Medical Affairs is increasingly playing a mission-critical role in bringing novel medicines to patients and working as a value-adding partner with R&D and commercial functions in pharma. In this webinar, a roundtable of experienced Medical Affairs leaders will discuss the opportunities and challenges evolving within their field, as well as the impact it can have on delivering great patient outcomes. The webinar will also explore how, while operating at an asset, above-asset and company-mission level, Medical Affairs can act as an organizational lead across the diverse areas of insight and evidence generation, scientific communication and engagement, patient advocacy and more.
In this webinar, we will show the views from a Therapeutic Area Lead responsible for establishing the insight objectives and ensuring action; a Field Medical Lead responsible for collecting and processing insights data; and a Strategic Program & Innovation Lead responsible for building & managing the program as well as ensuring actionable insight communication.
The objectives of this webinar are to present alternate views on a particular issue that is of concern to the Medical Affairs community while also attempting to resolve the issue.
This article outlines the aspects of Medical Affairs strategy and launch excellence specific to supporting the development and launch of treatments targeting rare diseases, providing a roadmap for MA teams and organizations undertaking this planning.
In this episode, MAPS speaks with Mark Michalski, former radiologist and currently Worldwide Head, Healthcare & Life Sciences, Artificial Intelligence and Machine Learning, Amazon Web Services about how we can catch up with big tech in our ability to mine data for meaning.
In Q&A format, this article summarizes key learnings from a MAPS 2022 Global Annual Meeting panel presented by the Medical Strategy FAWG.
This webinar will be covering:
1. Looking into the future of MA in Japan
a. How to engage more with Patients/Patient Advocacy groups
b. How to bring more value to customers, scientific leaders and health systems
c. How to better engage academia and health authority group through scientific exchange
2. Opportunities for improving effectiveness
a. Differentiation of MSL and Medical Rep roles- how are companies differentiating despite the regulations?